CCL vs STRO
Carnival Corporation (CCL) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Carnival Corporation (CCL) is a travel services company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CCL revenue for 2024-11-30 was $25.02B. Net income was $1.92B. Revenue was up 15.9% from 2023-11-30 to 2024-11-30. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CCL currently screens at market cap $39.74B and trailing P/E 15.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CCL and STRO stock pages for the full models.
Not investment advice.